VRDN R&D Expenses
Viridian Therapeutics Ors Inc · R&D Expenses
VRDN R&D Expenses
Latest reported$324.68Mperiod ending
VRDN TTM R&D Expenses ($29.82K → $324.68M)
TTM R&D Expenses
High-resolution chart · PNG
VRDN r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 324,676,000 | |
| 339,725,000 | |
| 338,929,000 | |
| 321,682,000 | |
| 304,579,000 | |
| 274,146,000 | |
| 238,255,000 | |
| 204,852,000 | |
| 166,079,000 | |
| 149,969,000 | |
| 159,765,000 | |
| 160,525,000 | |
| 152,259,000 | |
| 133,888,000 | |
| 100,894,000 | |
| 83,971,000 | |
| 69,973,000 | |
| 60,826,000 | |
| 56,886,000 | |
| 49,746,000 | |
| 44,736,000 | |
| 36,007,000 | |
| 28,304,000 | |
| 21,467,000 | |
| 27,383,000 | |
| 32,146,000 | |
| 34,794,000 | |
| 34,611,000 | |
| 32,983,000 | |
| 32,759,000 | |
| 30,421,000 | |
| 27,185,000 | |
| 24,804,000 | |
| 21,916,000 | |
| 19,623,000 | |
| 14,646,000 | |
| 9,854,000 | |
| 4,701,000 | |
| 888,000 | |
| 1,323,000 | |
| 1,350,000 | |
| 1,210,000 | |
| 1,003,000 | |
| 691,712 | |
| 514,926 | |
| 329,949 | |
| 238,656 | |
| 8,598 | |
| -21,012 | |
| -7,215 | |
| 29,821 |